Kleptoparasitic interactions modeling varying owner and intruder hunger awareness.

We consider a game theoretical model of kleptoparasitic interaction between two individuals, the Owner and the Intruder. The Owner is in possession of a resource and must decide whether to defend the resource against the Intruder or flee. If the Owner defends, the Intruder must decide whether to fight with the Owner or flee. The outcome of the fight depends on the hunger of the individuals, the hungrier the individual is, the more likely they are to win the fight. We consider three scenarios: (a) both individuals know their own and their opponent's hunger, (b) individuals only know their own hunger but not that of their opponent, and (c) individuals do not know their own nor the opponent's hunger levels. We determine Nash equilibrium strategies in each scenario. We conclude that Owner is generally willing to defend more often than the Intruder is willing to attack. Also, the Intruder's payoff is largest in the full information case; but the Owner may benefit in the no information or partial information cases when the cost of the fight is neither too large nor too small.

Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor Immunogenicity.

Cancer chemotherapeutic drugs have greatly advanced our ability to successfully treat a variety of human malignancies. The different forms of stress produced by these agents in cancer cells result in both cell autonomous and cell nonautonomous effects. Desirable cell autonomous effects include reduced proliferative potential, cellular senescence, and cell death. More recently recognized cell nonautonomous effects, usually in the form of stimulating an antitumor immune response, have significant roles in therapeutic efficiency for a select number of chemotherapies. Unfortunately, the success of these therapeutics is not universal as not all tumors respond to treatment, and those that do respond will frequently relapse into therapy-resistant disease. Numerous strategies have been developed to sensitize tumors toward chemotherapies as a means to either improve initial responses, or serve as a secondary treatment strategy for therapy-resistant disease. Recently, targeting epigenetic regulators has emerged as a viable method of sensitizing tumors to the effects of chemotherapies, many of which are cytotoxic. In this review, we summarize these strategies and propose a path for future progress.